Institutional

9 de August de 2017

Published ANVISA’s new rule relative to the prior consent for the granting of a patent for pharmaceutical products and processes

Valid since August 10 2017 – date of its publication on the Official Federal Gazette – this new rule confirms all the principals and procedures already stated on Normative Instruction Nº 01, from May 31 2017.

In case you need further information on this topic, our legal and technical teams are at your disposal in our offices of Rio de Janeiro, São Paulo and Porto Alegre, as well as the email: mail@kasznarleonardos.com

Back

Last related news

13 de March de 2026

Federal Court in Brazil invalidates chemical patent after nearly two decades of litigation

Our firm successfully represented a company operating in the offshore oil and gas sector in a lawsuit challenging the validity of a Brazilian patent … Federal Court in Brazil invalidates chemical patent after nearly two decades of litigation

Kasznar Leonardos

5 de March de 2026

Kasznar Leonardos has been ranked by Análise Advocacia Mulher 2026

We are honored to announce that four attorneys from Kasznar Leonardos have been recognized by Análise Advocacia Mulher 2026, organized by Análise Editorial! … Kasznar Leonardos has been ranked by Análise Advocacia Mulher 2026

Kasznar Leonardos

10 de February de 2026

Kasznar Leonardos was ranked in 2025 Outstanding International IP Service Teams

We are honored to announce that, for the second year in a row, we have been recognized in the “Outstanding International IP … Kasznar Leonardos was ranked in 2025 Outstanding International IP Service Teams

Kasznar Leonardos